igf-1 lr3 muscle growth evidence The mighty protein: insulin-like factor type 1 Unlocking the Power of IGF-1
Description
Tumor Biol 25 : 200207 Kalebic T, Tsokos M, Helman LJ (1994) In vivo treatment with antibody against IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down-regulates p34cdc2
While minor non-EV proteins may still be present, subsequent analyses focused on proteins consistently enriched in EV fractions across all samples to minimize potential confounding effects on proteomic profiling
It is provided after an individual consultation
[DOI] [PubMed] [Google Scholar] 31.Marin-Kuan M., Ehrlich V., Delatour T., Cavin C., Schilter B
